We present a successful case of remote robotic nipple-sparing mastectomy (rNSM), which preliminarily confirms its technical feasibility and perioperative safety.<h4>Case presentation</h4>A 50-year-old woman with multicentric, HER2-positive early-stage breast cancer accepted rNSM in January 2025. This evidence concerns the gene ERBB2 and breast cancer.